Patent for potential drug to treat major depressive disorder
Recently, Suven Life Sciences Ltd has secured a product patent in the US corresponding to a new chemical entity for the treatment of disorders associated with neurodegenerative diseases. Patent no. USA (8653071)corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases and this Patent is valid through 2030. Hyderabad based …
Patent for potential drug to treat major depressive disorder Read More »
